Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.

por Jabrane-Ferrat, N., Calvo, F., Faille, A., Lagabrielle, J. F., Boisson, N., Quillet, A., Fradelizi, D.
Publicado 1990

First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy.

por Mir, L. M., Devauchelle, P., Quintin-Colonna, F., Delisle, F., Doliger, S., Fradelizi, D., Belehradek, J., Orlowski, S.
Publicado 1997